Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches

Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S56-8. doi: 10.1016/j.ijrobp.2007.04.081.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antigens, Neoplasm / analysis
  • Biomarkers / analysis
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases / analysis
  • Carcinoma, Squamous Cell / physiopathology*
  • Cell Hypoxia* / drug effects
  • Cell Hypoxia* / physiology
  • Electrodes
  • Etanidazole / administration & dosage
  • Etanidazole / analogs & derivatives
  • Etanidazole / metabolism
  • Head and Neck Neoplasms / physiopathology*
  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Hydrocarbons, Fluorinated / administration & dosage
  • Hydrocarbons, Fluorinated / metabolism
  • Intracellular Signaling Peptides and Proteins
  • Mitochondrial Proteins
  • Neoplasm Proteins / analysis
  • Nitroimidazoles / administration & dosage
  • Nitroimidazoles / metabolism
  • Osteopontin / blood
  • Oxygen / analysis
  • Oxygen / metabolism
  • Oxygen / therapeutic use
  • Partial Pressure
  • Radiation-Sensitizing Agents / therapeutic use
  • Tirapazamine
  • Triazines / therapeutic use

Substances

  • Antigens, Neoplasm
  • Biomarkers
  • HIGD1A protein, human
  • Hydrocarbons, Fluorinated
  • Intracellular Signaling Peptides and Proteins
  • Mitochondrial Proteins
  • Neoplasm Proteins
  • Nitroimidazoles
  • Radiation-Sensitizing Agents
  • Triazines
  • Osteopontin
  • Tirapazamine
  • Etanidazole
  • 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide
  • pimonidazole
  • CA9 protein, human
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases
  • Oxygen